Class information for:
Level 1: BUPRENORPHINE//BUPRENORPHINE NALOXONE//NORBUPRENORPHINE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
5388 1630 33.4 66%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
25 3       SUBSTANCE ABUSE//ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH//ALCOHOL 112030
1436 2             BUPRENORPHINE//METHADONE//SUBSTANCE ABUSE 7862
5388 1                   BUPRENORPHINE//BUPRENORPHINE NALOXONE//NORBUPRENORPHINE 1630

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BUPRENORPHINE authKW 5677019 42% 44% 683
2 BUPRENORPHINE NALOXONE authKW 743542 3% 71% 56
3 NORBUPRENORPHINE authKW 693549 2% 97% 38
4 TRANSDERMAL BUPRENORPHINE authKW 322002 1% 90% 19
5 OPIOID DEPENDENCE authKW 306974 6% 16% 103
6 SUBOXONE authKW 292442 1% 71% 22
7 OPIOID RELATED DISORDERS authKW 185207 2% 26% 38
8 EVALUAT INFORMAT PHARMACODEPENDANCE ADDICTO address 183234 1% 65% 15
9 CEIP address 150735 1% 62% 13
10 OFFICE BASED TREATMENT authKW 137930 1% 82% 9

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Substance Abuse 76170 32% 1% 521
2 Psychiatry 6463 23% 0% 379
3 Pharmacology & Pharmacy 3187 27% 0% 444
4 Psychology, Clinical 1956 8% 0% 133
5 Anesthesiology 1576 6% 0% 101
6 Medicine, General & Internal 728 11% 0% 183
7 Medicine, Legal 267 1% 0% 24
8 Primary Health Care 210 1% 0% 20
9 Health Care Sciences & Services 194 3% 0% 45
10 Chemistry, Analytical 190 6% 0% 100

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 EVALUAT INFORMAT PHARMACODEPENDANCE ADDICTO 183234 1% 65% 15
2 CEIP 150735 1% 62% 13
3 CEIP MARSEILLE 131121 0% 100% 7
4 EVALUAT INFORMAT PHARMACODEPENDANCE 57358 0% 44% 7
5 CEIP TOULOUSE 56195 0% 100% 3
6 PACA CORSE ASSOCIE 56195 0% 100% 3
7 SANTE PUBLEA 3279 56195 0% 100% 3
8 EVALUAT INFORMAT PHARMACODEPENDENCE 52028 0% 56% 5
9 PHARMACOL THER IES 52028 0% 56% 5
10 HUMAN TOXICOL 45749 1% 11% 22

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DRUG AND ALCOHOL DEPENDENCE 54239 8% 2% 132
2 JOURNAL OF SUBSTANCE ABUSE TREATMENT 47252 5% 3% 77
3 JOURNAL OF ADDICTION MEDICINE 40578 2% 7% 32
4 AMERICAN JOURNAL ON ADDICTIONS 29513 3% 3% 46
5 HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS 28730 1% 9% 18
6 JOURNAL OF ADDICTIVE DISEASES 15000 2% 3% 25
7 THERAPIE 11162 2% 2% 39
8 SUBSTANCE ABUSE 10750 1% 4% 15
9 EUROPEAN ADDICTION RESEARCH 10697 1% 3% 19
10 ADDICTION 9394 3% 1% 46

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 BUPRENORPHINE 5677019 42% 44% 683 Search BUPRENORPHINE Search BUPRENORPHINE
2 BUPRENORPHINE NALOXONE 743542 3% 71% 56 Search BUPRENORPHINE+NALOXONE Search BUPRENORPHINE+NALOXONE
3 NORBUPRENORPHINE 693549 2% 97% 38 Search NORBUPRENORPHINE Search NORBUPRENORPHINE
4 TRANSDERMAL BUPRENORPHINE 322002 1% 90% 19 Search TRANSDERMAL+BUPRENORPHINE Search TRANSDERMAL+BUPRENORPHINE
5 OPIOID DEPENDENCE 306974 6% 16% 103 Search OPIOID+DEPENDENCE Search OPIOID+DEPENDENCE
6 SUBOXONE 292442 1% 71% 22 Search SUBOXONE Search SUBOXONE
7 OPIOID RELATED DISORDERS 185207 2% 26% 38 Search OPIOID+RELATED+DISORDERS Search OPIOID+RELATED+DISORDERS
8 OFFICE BASED TREATMENT 137930 1% 82% 9 Search OFFICE+BASED+TREATMENT Search OFFICE+BASED+TREATMENT
9 METHADONE 133231 8% 6% 124 Search METHADONE Search METHADONE
10 SUBUTEX 108980 0% 73% 8 Search SUBUTEX Search SUBUTEX

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 JOHNSON, RE , STRAIN, EC , AMASS, L , (2003) BUPRENORPHINE: HOW TO USE IT RIGHT.DRUG AND ALCOHOL DEPENDENCE. VOL. 70. ISSUE . P. S59-S77 114 90% 99
2 JOHNSON, RE , FUDALA, PJ , PAYNE, R , (2005) BUPRENORPHINE: CONSIDERATIONS FOR PAIN MANAGEMENT.JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. VOL. 29. ISSUE 3. P. 297-326 112 63% 111
3 MATTICK, RP , BREEN, C , KIMBER, J , DAVOLI, M , (2014) BUPRENORPHINE MAINTENANCE VERSUS PLACEBO OR METHADONE MAINTENANCE FOR OPIOID DEPENDENCE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - 52 60% 131
4 ORMAN, JS , KEATING, GM , (2009) BUPRENORPHINE/NALOXONE A REVIEW OF ITS USE IN THE TREATMENT OF OPIOID DEPENDENCE.DRUGS. VOL. 69. ISSUE 5. P. 577 -607 70 82% 46
5 ROBINSON, SE , (2006) BUPRENORPHINE-CONTAINING TREATMENTS - PLACE IN THE MANAGEMENT OF OPIOID ADDICTION.CNS DRUGS. VOL. 20. ISSUE 9. P. 697-712 94 73% 7
6 WESSON, DR , SMITH, DE , (2010) BUPRENORPHINE IN THE TREATMENT OF OPIATE DEPENDENCE.JOURNAL OF PSYCHOACTIVE DRUGS. VOL. 42. ISSUE 2. P. 161-175 69 85% 19
7 LAW, FD , MYLES, JS , DAGLISH, MRC , NUTT, DJ , (2004) THE CLINICAL USE OF BUPRENORPHINE IN OPIATE ADDICTION: EVIDENCE AND PRACTICE.ACTA NEUROPSYCHIATRICA. VOL. 16. ISSUE 5. P. 246-274 85 76% 15
8 WALSH, SL , EISSENBERG, T , (2003) THE CLINICAL PHARMACOLOGY OF BUPRENORPHINE: EXTRAPOLATING FROM THE LABORATORY TO THE CLINIC.DRUG AND ALCOHOL DEPENDENCE. VOL. 70. ISSUE . P. S13-S27 58 89% 86
9 LOFWALL, MR , WALSH, SL , (2014) A REVIEW OF BUPRENORPHINE DIVERSION AND MISUSE: THE CURRENT EVIDENCE BASE AND EXPERIENCES FROM AROUND THE WORLD.JOURNAL OF ADDICTION MEDICINE. VOL. 8. ISSUE 5. P. 315 -326 54 70% 13
10 AMASS, L , LING, W , FREESE, TE , REIBER, C , ANNON, JJ , COHEN, AJ , MCCARTY, D , REID, MS , BROWN, LS , CLARK, C , ET AL (2004) BRINGING BUPRENORPHINE-NALOXONE DETOXIFICATION TO COMMUNITY TREATMENT PROVIDERS: THE NIDA CLINICAL TRIALS NETWORK FIELD EXPERIENCE.AMERICAN JOURNAL ON ADDICTIONS. VOL. 13. ISSUE . P. S42-S66 56 81% 74

Classes with closest relation at Level 1


Rank Class id link
1 12818 LOFEXIDINE//NALTREXONE//6 BETA NALTREXOL
2 1986 METHADONE MAINTENANCE TREATMENT//METHADONE//METHADONE MAINTENANCE
3 14642 METHADONE//EDDP//2 ETHYLIDENE 1 5 DIMETHYL 3 3 DIPHENYLPYRROLIDINE
4 12122 NEONATAL ABSTINENCE SYNDROME//METHADONE//BUPRENORPHINE
5 1265 OPIOIDS//CHRONIC NONCANCER PAIN//PRESCRIPTION OPIOIDS
6 15291 BEHAV HLTH HUMAN SERV DELIVERY//JOURNAL OF SUBSTANCE ABUSE TREATMENT//BEHAV
7 8246 DRUG DISCRIMINATION//BEHAVIOURAL PHARMACOLOGY//SUBJECTIVE EFFECTS
8 28895 DESOMORPHINE//COUGH MIXTURE//KROKODIL
9 11030 OVERDOSE//DRUG RELATED DEATHS//OVERDOSE PREVENTION
10 21894 INTRA ARTERIAL INJECTION//GROIN INJECTING//SKIN POPPING

Go to start page